Aktis Oncology Inc's ROI from its second quarter of 2026 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aktis Oncology Inc's ROI in the second quarter of 2026?
Aktis Oncology Inc recorded a cumulative net loss of $-76 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -31.7%.

Within the Technology sector 427 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3767 to 3782.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Sep 30 2024) I. Quarter
Y / Y Investment Change TTM	238.31 %	-1.96 %	-	-73.47 %	-51.23 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	525	549	-98	-23	-11
Return On Investment (TTM)	-31.7 %	-55.55 %	-	-	-
AKTS's Overall Ranking	# 3782	# 3767	#	#	#
Seq. Investment Change TTM	128.99 %	-	-	-47.55 %	-33.64 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-76	-58	-69	-74	-75

AKTS Company Profile >> Back to AKTS Roi Comparisons >> See Annual AKTS Return On Investment

Return On Investment AKTS's Ranking
Within:	No.
Industry	# 26
Sector	# 428
Overall	# 3782

Return On Investment Statistics
High	Average	Low
-31.7 %	-85.78 %	-202.61 %
(Jun 30 2026)		(Sep 30 2024)

Financial Statements
Aktis Oncology Inc's II. Quarter Investments	$ 525 Millions	AKTS's Balance sheet
Aktis Oncology Inc's II. Quarter Income	$ -24 Millions	Quarterly AKTS's Income Statement
AKTS's Income by Division		See AKTS's Income by Division

AKTS Annual Return On Investment	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021	(Jun 30 2020) 2020
Total Investments in Millions	-11	131	149	118	89
Y / Y Investment Growth	-	-11.66 %	25.95 %	32.47 %	40.31 %
Net Income in Millions	-168	-64	-59	-44	-36
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-48.39 %	-39.81 %	-37.41 %	-40.56 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Consumer Electronics Industry Roi Trends and Statistics
Technology Sector Return On Investment Statistics
Roi Trends for overall market
AKTS's Roi Ratio versus Consumer Electronics Industry, Technology Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AKTS's Competitors
Subscribers only: Roi for Aktis Oncology Inc's Suppliers
Subscribers only: Return On Investment for AKTS's Customers

Other Ratios
AKTS's Roa	AKTS's Inventory Turnover Ratio	AKTS's Growth Rates	AKTS's Dividend Statistics
	AKTS's Profitability Ratios	AKTS's Asset Turnover Ratio	AKTS's Dividend Growth
AKTS's Roe	AKTS's Valuation Ratios	AKTS's Financial Strength Ratios	AKTS's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Technology Sector

ROI

Date modified: 2026-09-26T07:43:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.